000 | 01150cam a2200301 a 4500 | ||
---|---|---|---|
001 | ocm27143771 | ||
003 | OCoLC | ||
005 | 20160608160142.0 | ||
008 | 921027s1992 nyu b 001 0 eng | ||
010 | _a 92050733 | ||
020 |
_a0670841838 : _c$23.00 ($29.99 Can.) |
||
040 |
_aDLC _cDLC _dVET _dMLX _dOCL _dHSA |
||
050 | 0 | 0 |
_aRC483.5.F55 _bK7 1993 |
082 | 0 | 0 |
_a616.85/27061 _220 |
100 | 1 |
_aKramer, Peter D. _919014 |
|
245 | 1 | 0 | _aListening to Prozac / |
260 |
_aNew York : _bViking, _c1993. |
||
300 |
_axix, 409 p. ; _c24 cm. |
||
504 | _aIncludes bibliographical references and index. | ||
505 | 0 | _aMakeover -- Compulsion -- Antidepressants -- Sensitivity -- Stress --Risk -- Formes frustes: low self-esteem -- Formes frustes: inhibition of pleasure, sluggishness of thought -- The message in the capsule. | |
650 | 0 |
_aFluoxetine _xMoral and ethical aspects. _919015 |
|
650 | 0 |
_aFluoxetine _xPsychotropic effects. _919016 |
|
650 | 0 |
_aFluoxetine _xSocial aspects. _919017 |
|
650 | 0 |
_aPersonality change. _919018 |
|
650 | 2 |
_aEthics, Medical. _919019 |
|
650 | 2 |
_aFluoxetine. _919020 |
|
942 |
_2ddc _cNF |
||
999 |
_c28774 _d28774 |